
Company valuation, historical trends, and peer comparisons.
According to Impact BioMedical Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 35.02M. This represents a change of -13.08% compared to the average of 40.29M of the last 4 quarters.
The mean historical Enterprise Value of Impact BioMedical Inc. over the last ten years is 62.13M. The current 35.02M Enterprise Value has changed -43.64% with respect to the historical average. Over the past ten years (40 quarters), IBO's Enterprise Value was at its highest in in the September 2024 quarter at 149.34M. The Enterprise Value was at its lowest in in the September 2019 quarter at 0.
Average
62.13M
Median
42.05M
Minimum
15.92M
Maximum
173.53M
Discovering the peaks and valleys of Impact BioMedical Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 325.30%
Maximum Annual Enterprise Value = 173.53M
Minimum Annual Increase = -76.39%
Minimum Annual Enterprise Value = 15.92M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 15.92M | -76.39% |
| 2024 | 67.43M | -61.14% |
| 2023 | 173.53M | 325.30% |
| 2022 | 40.80M | -5.75% |
| 2021 | 43.29M | 36.06% |
The current Enterprise Value of Impact BioMedical Inc. (IBO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
85.63M
5-year avg
68.19M
10-year avg
62.13M
Impact BioMedical Inc.’s Enterprise Value is greater than NeuroSense Therapeutics Ltd. (3.32M), greater than AIM ImmunoTech Inc. (400.18K), greater than Brainstorm Cell Therapeutics Inc. (10.49M), greater than Alaunos Therapeutics, Inc. (6.41M), less than Moolec Science S.A. (247.13M), less than Cyclerion Therapeutics, Inc. (141.09M), greater than Quoin Pharmaceuticals, Ltd. (5.12M), less than Adial Pharmaceuticals, Inc. (0), greater than XTL Biopharmaceuticals Ltd. (4.58M), greater than Xenetic Biosciences, Inc. (-1515940.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 3.32M | $3.55M | |
| 400.18K | $6.38M | |
| 10.49M | $9.14M | |
| 6.41M | $6.54M | |
| 247.13M | $1.02M | |
| 141.09M | $15.73M | |
| 5.12M | $8.97M | |
| 0 | $13.26M | |
| 4.58M | $1.54M | |
| -1515940.00 | $4.96M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Impact BioMedical Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Impact BioMedical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Impact BioMedical Inc.'s Enterprise Value?
What is the highest Enterprise Value for Impact BioMedical Inc. (IBO)?
What is the 3-year average Enterprise Value for Impact BioMedical Inc. (IBO)?
What is the 5-year average Enterprise Value for Impact BioMedical Inc. (IBO)?
How does the current Enterprise Value for Impact BioMedical Inc. (IBO) compare to its historical average?